In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - IIT-STEINECK-CARTPLUS
Protocol Summary
- Protocol No
- IIT-STEINECK-CARTPLUS
- Principal Investigator
- Angela Steineck
- Phase
- N/A
- Title
- IIT-Steineck-CARTPLUS: Chimeric Antigen Receptor T-cell Pediatrics Living with Uncertainty (CAR T-PLUS) Intervention Proof of Concept Study
- Associated Disease(s)
-
Bone Marrow Transplant and Cellular Therapy
- Description (Summary)
- The purpose of this project is to improve patient and family HRQOL by addressing uncertainty and optimizing symptom management. We are aiming to develop an intervention specific to the supportive care needs of pediatric patients who are completing CAR T-cell therapy.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
